Invention Grant
US08435543B2 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
有权
基因间区域作为修饰的痘苗病毒安卡拉（MVA）基因组中的插入位点
- Patent Title: Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
- Patent Title (中): 基因间区域作为修饰的痘苗病毒安卡拉（MVA）基因组中的插入位点
-
Application No.: US13234230Application Date: 2011-09-16
-
Publication No.: US08435543B2Publication Date: 2013-05-07
- Inventor: Paul Howley , Sonja Leyrer
- Applicant: Paul Howley , Sonja Leyrer
- Applicant Address: DK Kvistgaard
- Assignee: Bavarian Nordic A/S
- Current Assignee: Bavarian Nordic A/S
- Current Assignee Address: DK Kvistgaard
- Agency: Law Office of Salvatore Arrigo and Scott Lee, LLP
- Priority: DK20020752 20020516; DK20020753 20020516
- Main IPC: A61K39/12
- IPC: A61K39/12 ; A61K39/21 ; A61K39/193 ; A61K39/285
Abstract:
The present invention relates to novel insertion sites useful for the integration of exogenous sequences into the Modified Vaccinia Ankara (MVA) virus genome. The present invention further provides plasmid vectors to insert exogenous DNA into the genome of MVA. Furthermore, the present invention provides recombinant MVA comprising an exogenous DNA sequence inserted into the new insertion site as medicine or vaccine.
Public/Granted literature
- US20120082696A1 INTERGENIC REGIONS AS INSERTION SITES IN THE GENOME OF MODIFIED VACCINIA VIRUS ANKARA (MVA) Public/Granted day:2012-04-05
Information query
